X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19350) 19350
Newspaper Article (859) 859
Newsletter (737) 737
Book Chapter (69) 69
Book / eBook (37) 37
Magazine Article (30) 30
Dissertation (7) 7
Conference Proceeding (4) 4
Web Resource (4) 4
Reference (2) 2
Book Review (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17470) 17470
male (9431) 9431
female (9357) 9357
oncology (8855) 8855
middle aged (7798) 7798
head and neck neoplasms - drug therapy (7318) 7318
cancer (6957) 6957
aged (6672) 6672
adult (5825) 5825
head and neck cancer (5400) 5400
head (4912) 4912
carcinoma, squamous cell - drug therapy (4839) 4839
chemotherapy (4596) 4596
radiotherapy (4362) 4362
head and neck neoplasms - pathology (3941) 3941
head and neck neoplasms - radiotherapy (3583) 3583
squamous cell carcinoma (3316) 3316
care and treatment (3304) 3304
carcinoma, squamous cell - pathology (3242) 3242
squamous-cell carcinoma (3200) 3200
surgery (2981) 2981
treatment outcome (2936) 2936
research (2795) 2795
combined modality therapy (2756) 2756
antineoplastic combined chemotherapy protocols - therapeutic use (2642) 2642
animals (2549) 2549
otorhinolaryngology (2519) 2519
prognosis (2386) 2386
head & neck cancer (2356) 2356
aged, 80 and over (2327) 2327
tumors (2303) 2303
cell line, tumor (2221) 2221
antineoplastic agents - therapeutic use (2140) 2140
neck-cancer (2140) 2140
head and neck neoplasms - therapy (2126) 2126
carcinoma, squamous cell - radiotherapy (2027) 2027
cisplatin (1971) 1971
neck (1882) 1882
cisplatin - administration & dosage (1859) 1859
neoplasm staging (1842) 1842
analysis (1825) 1825
radiation therapy (1805) 1805
retrospective studies (1798) 1798
mice (1713) 1713
carcinoma (1711) 1711
cancer therapies (1698) 1698
metastasis (1686) 1686
expression (1526) 1526
head and neck neoplasms - metabolism (1519) 1519
health aspects (1519) 1519
therapy (1515) 1515
radiology, nuclear medicine & medical imaging (1514) 1514
radiation-therapy (1478) 1478
squamous cell carcinoma of head and neck (1460) 1460
radiation (1458) 1458
apoptosis (1431) 1431
survival (1423) 1423
patients (1374) 1374
carcinoma, squamous cell - metabolism (1361) 1361
medicine & public health (1348) 1348
carcinoma, squamous cell - therapy (1320) 1320
head and neck neoplasms - mortality (1316) 1316
hematology, oncology and palliative medicine (1297) 1297
follow-up studies (1290) 1290
head and neck neoplasms - surgery (1287) 1287
oncology, experimental (1281) 1281
head and neck neoplasms - genetics (1208) 1208
fluorouracil - administration & dosage (1205) 1205
carcinoma, squamous cell - genetics (1162) 1162
dentistry, oral surgery & medicine (1160) 1160
carcinoma, squamous cell - mortality (1143) 1143
survival rate (1141) 1141
disease-free survival (1121) 1121
medicine (1067) 1067
risk factors (1067) 1067
drug therapy (1056) 1056
chemoradiotherapy (1042) 1042
survival analysis (1032) 1032
radiotherapy dosage (1005) 1005
antineoplastic agents - administration & dosage (996) 996
prospective studies (986) 986
antineoplastic agents - pharmacology (965) 965
cetuximab (964) 964
immunohistochemistry (950) 950
adolescent (942) 942
antineoplastic combined chemotherapy protocols - adverse effects (886) 886
locally advanced head (868) 868
mice, nude (848) 848
time factors (846) 846
medical research (840) 840
otolaryngology (840) 840
cancer patients (834) 834
gene expression (832) 832
drug administration schedule (826) 826
antineoplastic agents - adverse effects (820) 820
cisplatin - therapeutic use (819) 819
medical prognosis (818) 818
diagnosis (815) 815
quality of life (808) 808
carcinoma, squamous cell - surgery (807) 807
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (9) 9
Online Resources - Online (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Scarborough Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20234) 20234
Japanese (345) 345
German (318) 318
French (217) 217
Italian (64) 64
Chinese (61) 61
Spanish (59) 59
Russian (43) 43
Polish (34) 34
Portuguese (34) 34
Hungarian (16) 16
Czech (8) 8
Dutch (8) 8
Danish (7) 7
Swedish (5) 5
Hebrew (4) 4
Norwegian (4) 4
Croatian (3) 3
Romanian (3) 3
Ukrainian (2) 2
Amharic (1) 1
Arabic (1) 1
Finnish (1) 1
Korean (1) 1
Serbian (1) 1
Turkish (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 967 - 975
Abstract Purpose To assess the impact of radiation treatment time (RTT) in head and neck cancers on overall survival (OS... 
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | CONCURRENT CHEMOTHERAPY | LARYNGEAL-CANCER | THERAPY ONCOLOGY GROUP | SQUAMOUS-CELL CARCINOMA | RANDOMIZED-TRIAL | STANDARD FRACTIONATION | LOCALLY ADVANCED HEAD | 1ST REPORT | PROLONGATION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Radiotherapy - mortality | Humans | Oropharyngeal Neoplasms - mortality | Chemoradiotherapy - mortality | Hypopharyngeal Neoplasms - mortality | Tongue Neoplasms - drug therapy | Time Factors | Laryngeal Neoplasms - drug therapy | Tongue Neoplasms - radiotherapy | Tongue Neoplasms - mortality | Chemoradiotherapy - methods | Oropharyngeal Neoplasms - drug therapy | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Oropharyngeal Neoplasms - radiotherapy | Chi-Square Distribution | Tonsillar Neoplasms - mortality | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Analysis of Variance | Laryngeal Neoplasms - mortality | Tonsillar Neoplasms - radiotherapy | Survival Analysis | Tonsillar Neoplasms - drug therapy | Head and Neck Neoplasms - mortality | Hypopharyngeal Neoplasms - drug therapy | Care and treatment | Cancer patients | Radiotherapy | Patient outcomes | Radiation | Cancer | HEAD | PATIENTS | SURVIVAL TIME | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LYMPHATIC SYSTEM | CHEMOTHERAPY | Head and Neck Cancer | Treatment time | National Cancer Database | Squamous Cell
Journal Article
Seminars in oncology, ISSN 0093-7754, 2015, Volume 42, Issue 6, pp. 801 - 819
.... Most of these molecular alterations promote multiple steps of carcinogenesis in FGFR oncogene-addicted cells, increasing cell proliferation, angiogenesis, and drug resistance... 
BREAST-CANCER | LUNG-CANCER | IN-VITRO | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RESISTANCE | GENE AMPLIFICATION | POTENTIAL THERAPEUTIC TARGET | PROGNOSTIC-SIGNIFICANCE | ANTITUMOR-ACTIVITY | EXPRESSION | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Brain Neoplasms - pathology | Fibroblast Growth Factors - genetics | Brain Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Gastrointestinal Neoplasms - pathology | Glioblastoma - genetics | Receptors, Fibroblast Growth Factor - genetics | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Gastrointestinal Neoplasms - metabolism | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - drug therapy | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Thoracic Neoplasms - pathology | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Thoracic Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Breast Neoplasms - genetics | Thoracic Neoplasms - genetics | Breast Neoplasms - pathology | Glioblastoma - pathology | Receptors, Fibroblast Growth Factor - metabolism | Head and Neck Neoplasms - genetics | Fibroblast Growth Factors - antagonists & inhibitors | Thoracic Neoplasms - drug therapy | Glioblastoma - drug therapy | Neoplasms - pathology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1360 - 1368
... followed by chemoradiotherapy with intensity-modulated radiation therapy (C-IMRT) for head-and-neck cancer patients... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Volume changes | Chemo-IMRT | Dosimetric changes | SYSTEM | DELINEATION | IMRT | ONCOLOGY | GUIDELINES | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Prospective Studies | Humans | Oropharyngeal Neoplasms - diagnostic imaging | Spinal Cord - radiation effects | Laryngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Time Factors | Laryngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Brain Stem - radiation effects | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - drug therapy | Parotid Gland - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Head and Neck Neoplasms - pathology | Radiography | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Parotid Gland - radiation effects | Hypopharyngeal Neoplasms - pathology | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Hypopharyngeal Neoplasms - diagnostic imaging | Care and treatment | Chemotherapy | Oncology, Experimental | Radiation | Research | Radiotherapy | Cancer | TOMOGRAPHY | HEAD | DIAGNOSTIC TECHNIQUES | NEOPLASMS | RADIATION DOSES | MEDICINE | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | CAT SCANNING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | BODY | COMBINED THERAPY | RADIOLOGY
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1078 - 1085
... [HPV(+)] versus human papillomavirus-unrelated [HPV(−)] head-and-neck cancer (HNC). Methods and Materials All cases of N2-N3 HNC treated with radiation therapy/chemoradiation therapy between 2003 and 2009 were reviewed... 
Radiology | Hematology, Oncology and Palliative Medicine | METASTASIS | ONCOLOGY | DISSECTION | OROPHARYNGEAL CANCER | LYMPH-NODES | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Lymph Nodes - pathology | Hypopharyngeal Neoplasms - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Laryngeal Neoplasms - pathology | Lymph Nodes - radiation effects | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Papillomavirus Infections - virology | Remission Induction - methods | Oropharyngeal Neoplasms - drug therapy | Laryngeal Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Organ Size | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Lymph Nodes - virology | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Head and Neck Neoplasms - surgery | Cohort Studies | Laryngeal Neoplasms - virology | Neck Dissection | Sects | Care and treatment | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | HEAD | MULTIVARIATE ANALYSIS | NEOPLASMS | LYMPH NODES | POSITRON COMPUTED TOMOGRAPHY | CHARGES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LARYNX | HAZARDS
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 126 - 134
Purpose To perform a comprehensive cognitive function (CF) assessment in patients who were relapse free after curative intent radiotherapy (RT... 
Radiology | Hematology, Oncology and Palliative Medicine | Squamous cell carcinoma of the head and neck | Chemotherapy | Neuropsychological testing | Radiotherapy | Cognitive dysfunction | PROPHYLACTIC CRANIAL IRRADIATION | ADJUVANT CHEMOTHERAPY | DRIVING PERFORMANCE | FOLLOW-UP | CELL LUNG-CANCER | BREAST-CANCER | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | NEUROCOGNITIVE FUNCTION | LOW-GRADE GLIOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - radiotherapy | Cerebellum - radiation effects | Prospective Studies | Humans | Middle Aged | Male | Pharyngeal Neoplasms - drug therapy | Antineoplastic Agents - administration & dosage | Cognition - physiology | Laryngeal Neoplasms - drug therapy | Neoplasms, Squamous Cell - pathology | Carcinoma - drug therapy | Carcinoma - blood | Affect - physiology | Head and Neck Neoplasms - drug therapy | Cognition - drug effects | Neoplasms, Squamous Cell - blood | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell | Neuropsychological Tests | Cognition Disorders - diagnosis | Memory Disorders - etiology | Hypopharyngeal Neoplasms - pathology | Quality of Life | Pharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - drug therapy | Temporal Lobe - drug effects | Laryngeal Neoplasms - blood | Cerebellum - drug effects | Hypopharyngeal Neoplasms - blood | Cisplatin - administration & dosage | Feasibility Studies | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - blood | Antineoplastic Agents - adverse effects | Cognition Disorders - etiology | Neoplasms, Squamous Cell - drug therapy | Neoplasms, Squamous Cell - radiotherapy | Female | Carcinoma - pathology | Cognition - radiation effects | Affect - drug effects | Pharyngeal Neoplasms - blood | Affect - radiation effects | Carcinoma - radiotherapy | Combined Modality Therapy - adverse effects | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Cisplatin - adverse effects | Aged | Combined Modality Therapy - methods | Temporal Lobe - radiation effects | Care and treatment | Squamous cell carcinoma | Cancer | BODY FLUIDS | HEAD | NERVOUS SYSTEM | RADIATION DOSES | MEDICINE | THERAPY | CEREBELLUM | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | BRAIN | RADIOLOGY | BLOOD | NEOPLASMS | BIOLOGICAL MATERIALS | CENTRAL NERVOUS SYSTEM | STANDARD OF LIVING | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | CARCINOMAS | NECK | DOSIMETRY | BODY | MATERIALS
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 291 - 298
Purpose To update the Memorial Sloan-Kettering Cancer Center’s experience with intensity-modulated radiotherapy (IMRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck cancer | Dysphagia | IMRT | Xerostomia | Oropharyngeal cancer | HEAD | CHEMORADIOTHERAPY | NECK-CANCER | RADIATION-THERAPY | SALIVARY FUNCTION | IMPACT | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Pharyngeal Neoplasms - radiotherapy | Follow-Up Studies | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Palate, Soft | Male | Oropharyngeal Neoplasms - pathology | Pharyngeal Neoplasms - drug therapy | Tongue Neoplasms - drug therapy | Incidence | New York City | Palatal Neoplasms - mortality | Treatment Failure | Aged, 80 and over | Adult | Female | Xerostomia - epidemiology | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Tongue Neoplasms - mortality | Tonsillar Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Palatal Neoplasms - radiotherapy | Deglutition Disorders - epidemiology | Palatal Neoplasms - pathology | Oropharyngeal Neoplasms - radiotherapy | Cancer Care Facilities | Tonsillar Neoplasms - mortality | Tongue Neoplasms - pathology | Pharyngeal Neoplasms - mortality | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - drug therapy | Pharyngeal Neoplasms - pathology | Aged | Palatal Neoplasms - drug therapy | Neoplasm Staging | Radiotherapy, Intensity-Modulated | Care and treatment | Throat cancer | Radiotherapy | Nuclear radiation | Cancer | PATIENTS | NEOPLASMS | FAILURES | METASTASES | PLATINUM | RADIATION DOSES | LYMPHATIC SYSTEM | CHEMOTHERAPY | PLANNING | PHARYNX | TONGUE | WOMEN | MEN | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 74, Issue 2, pp. 477 - 481
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 5, pp. 1373 - 1380
Purpose To review outcome and toxicity of Stage IVa and IVb head-and-neck squamous cell carcinoma patients treated with concomitant chemotherapy and intensity-modulated radiotherapy (IMRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck cancer | Altered fractionation | Chemotherapy | IMRT | Head-and neck cancer | ACCELERATED RADIOTHERAPY | TOXICITY | OROPHARYNGEAL CARCINOMA | CANCER | RADIATION-THERAPY | PRESERVATION | DELINEATION | ONCOLOGY | CONCURRENT CHEMOTHERAPY | CHEMORADIATION | LOCALLY ADVANCED HEAD | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Mouth Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted - methods | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Male | Antineoplastic Agents - therapeutic use | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Laryngeal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Laryngeal Neoplasms - drug therapy | Adult | Dose Fractionation | Female | Mouth Neoplasms - radiotherapy | Retrospective Studies | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Combined Modality Therapy - adverse effects | Mouth Neoplasms - mortality | Head and Neck Neoplasms - pathology | Radiography | Xerostomia - prevention & control | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Organs at Risk - diagnostic imaging | Survival Analysis | Mouth Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Head and Neck Neoplasms - mortality | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Index Medicus | HEAD | NEOPLASMS | MEDICINE | IRRADIATION | FRACTIONATED IRRADIATION | DISEASES | THERAPY | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | BODY | COMBINED THERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 73, Issue 2, pp. 399 - 409
Purpose Institutional and cooperative group experience has demonstrated the feasibility of reirradiation for head and neck cancer... 
Radiology | Hematology, Oncology and Palliative Medicine | reirradiation | radiotherapy | IMRT | head and neck cancer | salvage | ONCOLOGY-GROUP | PROGNOSTIC-FACTORS | MODULATED RADIATION-THERAPY | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | FULL-DOSE REIRRADIATION | UNRESECTABLE HEAD | RECURRENT HEAD | SQUAMOUS-CELL CARCINOMA | SALVAGE SURGERY | CISPLATIN PLUS FLUOROURACIL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Neoplasm Recurrence, Local - radiotherapy | Humans | Middle Aged | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Carcinoma, Squamous Cell - surgery | Male | Carcinoma, Squamous Cell - radiotherapy | Neoplasm Recurrence, Local - mortality | Neoplasms, Second Primary - radiotherapy | Neoplasms, Second Primary - surgery | Neoplasm Recurrence, Local - surgery | Young Adult | Aged, 80 and over | Adult | Female | Retrospective Studies | Radiotherapy, Intensity-Modulated - mortality | Radiotherapy Dosage | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Radiation Dosage | Head and Neck Neoplasms - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Head and Neck Neoplasms - mortality | Neoplasms, Second Primary - drug therapy | Head and Neck Neoplasms - surgery | Retreatment - adverse effects | Head and neck cancer | Diagnostic imaging | Radiotherapy | Radiation | Index Medicus | SURGERY | HEAD | PATIENTS | DISEASE INCIDENCE | DEATH | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | IRRADIATION | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 846 - 853
...) intensity modulated proton therapy (IMPT) for patients with head and neck tumors. Methods and Materials Fifteen consecutive patients with head and neck cancer underwent MFO-IMPT with active scanning beam proton therapy... 
Radiology | Hematology, Oncology and Palliative Medicine | PHOTON | RADIOTHERAPY | ONCOLOGY | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Uncertainty | Follow-Up Studies | Humans | Middle Aged | Proton Therapy - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Tongue Neoplasms - drug therapy | Nasopharyngeal Neoplasms - radiotherapy | Adult | Female | Radiotherapy Setup Errors | Nasopharyngeal Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Carcinoma, Adenoid Cystic - drug therapy | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Stomatitis - etiology | Quality Assurance, Health Care | Head and Neck Neoplasms - radiotherapy | Pilot Projects | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Adenoid Cystic - radiotherapy | Proton Therapy - methods | Xerostomia - etiology | Head and neck tumors | Sects | Care and treatment | Nuclear radiation | Index Medicus | HEAD | MEV RANGE 10-100 | PATIENTS | CLINICAL TRIALS | PROTON BEAMS | SKULL | TOXICITY | MEV RANGE 100-1000 | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | OPTIMIZATION | NECK
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 83, Issue 2, pp. 720 - 726
Purpose To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiotherapy | Local control | Low risk | Rhabdomyosarcoma | PARAMENINGEAL RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | SURGICAL-MANAGEMENT | FAILURE | RADIATION-THERAPY | STUDY-IV | GROUP-III PATIENTS | ONCOLOGY | PATIENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Node Excision | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - surgery | Neoplasm, Residual | Young Adult | Rhabdomyosarcoma, Embryonal - secondary | Treatment Failure | Adult | Female | Urogenital Neoplasms - drug therapy | Orbital Neoplasms - surgery | Child | Infant, Newborn | Orbital Neoplasms - radiotherapy | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Quality Control | Prostatic Neoplasms - pathology | Drug Administration Schedule | Prostatic Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Orbital Neoplasms - pathology | Urogenital Neoplasms - pathology | Orbital Neoplasms - drug therapy | Lymphatic Metastasis | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Radiotherapy Dosage - standards | Urogenital Neoplasms - radiotherapy | Adolescent | Combined Modality Therapy - methods | Urogenital Neoplasms - surgery | Rhabdomyosarcoma, Embryonal - radiotherapy | Second-Look Surgery | Head and Neck Neoplasms - surgery | SURGERY | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | RADIOLOGY AND NUCLEAR MEDICINE | ENDOXAN | RADIATION DOSES | RADIOTHERAPY | CHILDREN | CONTROL | HAZARDS | Low-risk | Local Control
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 01/2018, Volume 110, Issue 1, pp. 109 - 120
.... Methods: CAF accumulation and prognostic significance in head and neck cancer (oral, n = 260; oropharyngeal, n = 271), and colorectal cancer... 
CELL LUNG-CANCER | PHASE-II TRIAL | OXIDATIVE STRESS | ONCOLOGY | NAB-PACLITAXEL | ACTIVATION PROTEIN | DEPENDENT INVASION | PANCREATIC-CANCER | MONOCLONAL-ANTIBODY | DIFFERENTIATION | STROMAL CELLS | Lung Neoplasms - drug therapy | Up-Regulation | Pyrazoles - therapeutic use | Reactive Oxygen Species - metabolism | Cell Count | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Head and Neck Neoplasms - chemistry | RNA Interference | Cancer-Associated Fibroblasts - chemistry | Aged, 80 and over | NADPH Oxidases - genetics | Adenocarcinoma - chemistry | Esophageal Neoplasms - chemistry | Lung Neoplasms - chemistry | NADPH Oxidases - antagonists & inhibitors | Head and Neck Neoplasms - drug therapy | Carcinoma, Squamous Cell - chemistry | Survival Rate | Adenocarcinoma - drug therapy | Disease Progression | Phenotype | Carcinoma, Squamous Cell - drug therapy | Head and Neck Neoplasms - genetics | Mice | Neoplasm Transplantation | Carcinoma, Non-Small-Cell Lung - chemistry | Carcinoma, Squamous Cell - genetics | Colorectal Neoplasms - chemistry | Cell Transdifferentiation - genetics | Myofibroblasts - chemistry | Actins - analysis | Cell Transdifferentiation - drug effects | Adult | Female | Adenocarcinoma - genetics | Cancer-Associated Fibroblasts - physiology | Pyridines - therapeutic use | Lung Neoplasms - genetics | Myofibroblasts - pathology | Carcinoma, Non-Small-Cell Lung - genetics | NADPH Oxidases - analysis | Mouth Neoplasms - chemistry | NADPH Oxidase 4 | Cancer-Associated Fibroblasts - pathology | Animals | Esophageal Neoplasms - genetics | Mouth Neoplasms - pathology | Oropharyngeal Neoplasms - chemistry | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Colorectal Neoplasms - pathology | Esophageal Neoplasms - drug therapy
Journal Article